Shanel A. Lindsay
Founder and President
Shanel Lindsay is an attorney, inventor, and cannabis advocate. Shanel graduated from the University of Pennsylvania and Northeastern University School of Law and began her career as a judicial law clerk for the Massachusetts Superior Court. She then joined the Boston law firm of Sugarman, Rogers, Barshak and Cohen, serving as a civil litigator for Fortune 500 companies in the areas of business, insurance, and employment law before becoming Employment Counsel and Director of Human Resources for the Massachusetts State Lottery Commission. Shanel is an active member of the National Bar Association, previously serving as Deputy Regional Director from 2009-2013 and currently as a regional board member. With over a decade of experience processing cannabis for medicinal use, Shanel leveraged that knowledge and skill set to develop the Nova and Ardent's suite of products that allow patients to expertly make accurate therapeutics using any strain or form of the plant. A founding member and Co-Chair of the Northeast Cannabis Coalition, Board Member of the Massachusetts Patients Advocacy Alliance, and ardent advocate for cannabis legalization on the east coast, Shanel is dedicated to improving public understanding of cannabis’ medicinal benefits. She is certain that with increased education, research, and reliable clinical data, patients and doctors—even those who have not previously considered cannabis as an option—will discover it is a legitimate, viable, and safe treatment. Learn more about Shanel's journey as a medical cannabis patient, advocate and entrepreneur.
Elizabeth G. Dost
Chief Clinical Officer
Elizabeth Dost is a registered nurse and senior health care executive with more than 20 years experience in the Boston-area health care market. Beth is a Certified Cannabis Nurse and Nominating Committee member of the American Cannabis Nurse Association, and an active member of the Society for Cannabis Clinicians, Americans for Safe Access, Patients Out of Time, and the National Hospice and Palliative Care Organization (NHPCO), where she serves on their speaker’s list. She also is a registered participant of My Compassion and the Medical Cannabis Institute. Prior to joining Ardent as Chief Clinical Officer, Beth was the Vice President and Executive Director of Guardian Hospice and Palliative Care, a non-profit hospice company that drove a culture of compassionate care to all persons and their loved ones seeking end-of-life health services and support. A passionate advocate for patients, her resume also includes; CEO and President of Primary Health Services, Inc., a premier pediatric home care company and nationally recognized provider of home care services to medically complex, fragile children who would otherwise face long-term hospitalization; CCO of a private duty aftercare and eldercare service company; and Director of Clinical Services for a skilled nursing home based hospice company.
Beth was awarded Ernst and Young, Merrill Lynch and Inc. Magazine’s Entrepreneur of the Year in Healthcare, New England Region, and is a member of the elite group Alumni. She has received Special Recognition by the Massachusetts’ Department of Public Health for services provided to a foster child suffering from AIDS, was an invited participant to the US Surgeon General’s Conference in Washington, DC, and is a sought after public speaker on cannabis, leadership, marketing, entrepreneurship, pain management, death and dying with dignity. Notably, Beth was called upon to speak statewide on behalf of all hospices in Massachusetts for the Coalition against Physician Assisted Suicide.
Steven Shelales has been an expert on nutraceutical products for over 17 years. His experience studying nutraceuticals in an academic environment, advising the public on their use, and gathering both empirical evidence and anecdotal data has provided him a keen perspective on the usefulness, validity and limitations of natural therapies. Steven earned his Masters of Science in Medical Laboratory Science and Biotechnology from the University of Rhode Island, summa cum laude, specializing in natural products science, stem cell science and the organismal theory of evolution. His master’s literature review investigated the varied uses of beta glucans from mushroom sources, their potency and their potential uses in the future of medicine.
Steven's research at the University of Rhode Island Pharmacognosy Lab involved studying novel sources of resveratrol, properties of rebaudioside-A and novel separation methods of reb-A from raw crude stevia extract, and the development of fast-dissolving films for nutraceutical delivery. He has broad knowledge of the scientific industry, having worked as a chemist at a chemical manufacturing and processing industrial facility, in quality control in the food industry, and in process development for biopharmaceuticals at a large biotech firm. Steven's primary expertise lies in developing formulations and extracts from raw sources in a variety of delivery forms.